Cresset Asset Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49K Buy
+10,000
New +$58.7K ﹤0.01% 1850
2023
Q1
– Sell
-315,719
Closed -$3.84M – 858
2022
Q4
$3.84M Hold
315,719
– – 0.05% 142
2022
Q3
$3.79M Hold
315,719
– – 0.05% 148
2022
Q2
$4.44M Hold
315,719
– – 0.05% 138
2022
Q1
$3.91M Buy
+315,719
New +$3.79M 0.04% 154

Other funds holding RXST

Cresset Asset Management's RXST Position: Q3 2026 in Review

Cresset Asset Management opened a new position in RxSight (RXST) in Q3 2026: 10,000 shares worth $49K. The stake represents ﹤0.01% of the portfolio and ranks #1850 among its holdings. This is a return to the name: Cresset Asset Management previously reported a position in RXST as recently as Q4 2022.

Cresset Asset Management first reported a position in RXST in Q1 2022 and has held it in 5 quarters since. The position peaked at $4.44M in Q2 2022. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Cresset Asset Management held 10,000 shares of RxSight worth $49K as of Q3 2026.
  • RxSight was a new Cresset Asset Management position in Q3 2026.
  • RxSight made up ﹤0.01% of Cresset Asset Management's portfolio in Q3 2026, its #1850 holding.
  • Cresset Asset Management first reported a position in RxSight in Q1 2022 and has held it in 5 quarters since.
  • Cresset Asset Management's RxSight position peaked at $4.44M in Q2 2022.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Cresset Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.